Clinical trial
Brain Chemical Receptor Effects in Patients With Panic Disorder and…
NCT00025974 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00025974 |
|---|---|
| Title | Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder |
| Official title | Serotonin 1A Receptor Imaging and Benzodiazepine Receptor Imaging in Panic Disorder and Posttraumatic Stress Disorder |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Panic Disorder, Posttraumatic Stress Disorder, Major Depressive Disorder |
| Enrollment | 230 |
| Start date | Oct 31, 2001 |
| Completion | Jul 21, 2008 |
| First posted | Nov 5, 2001 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: